Wells Fargo analyst Lawrence Biegelsen double-downgraded Glaukos (GKOS) and SeaSpine (SPNE) to Underweight from Overweight as part of his broader Medical Technology industry research note. The analyst expects the medical device sector to be part of the "politics of healthcare" storm heading into next year's elections given the focus on drug pricing and increasing access to healthcare, even though he sees the broader risks as "manageable" for another year with "medtech tax" likely to be suspended. Biegelsen also cuts his rating on Merit Medical (MMSI) to Underweight from Equal Weight, but offers a positive view on Medtronic (MDT), citing its accelerating growth story trading at a discount relative to peer valuation and sees Teleflex (TFX) as "among the best positioned" in his coverage with UroLift as its key growth accelerator.